是时候在已故的捐赠者身上进行NGS HLA输入了吗?
Michael D Gautreaux1, Shannon Mesa2, David Kiger1
1HLA/Immunogenetics and Immunodiagnostics Laboratories, Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC 27103, USA.
Human immunology
|February 5, 2025
概括
下一代测序 (NGS) 为已故捐赠者提供高分辨率的人类白细胞抗原 (HLA) 类型,这对于固体器官移植至关重要. 这个案例研究突出了NGS的重点.
科学领域:
- 免疫遗传学 免疫遗传学
- 移植科学 移植科学
背景情况:
- 越来越多的人类白细胞抗原 (HLA) 基因对传统的排序方法构成挑战.
- 目前对已故捐赠者 (DD) 的HLA类型化通常依赖于速度和分辨率有限的方法.
研究的目的:
- 评估下一代测序 (NGS) 对已故捐赠者的高分辨率HLA类型的有用性.
- 展示NGS在DD HLA类型中提高准确性和及时性的潜力.
主要方法:
- 案例研究涉及使用NGS对已故捐赠者的确认HLA类型.
- 将NGS结果与实时PCR执行的初始类型进行比较.
主要成果:
- NGS发现了HLA-A类型的差异,特别是一个零等位基因,最初的实时PCR方法错过了.
- 通过NGS方法,在临床上相关的时间框架内提供了高分辨率的打字.
结论:
- 下一代测序是一种可行且优越的方法,用于已故捐赠者的HLA类型.
- 建议采用NGS用于已故捐赠者的HLA类型,以提高移植兼容性和患者的结果.
更多相关视频
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.3K
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.5K
相关概念视频
Tissue Transplantation
332
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
332
Bone Marrow Sampling and Transplants
277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277
